| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.2174/1381612033453884 |
| P953 | full work available at URL | http://eurekaselect.com/article/download/63457 |
| P698 | PubMed publication ID | 14529396 |
| P2093 | author name string | George Boykow | |
| Michael P. Graziano | |||
| Carolyn Foster | |||
| Samuel Chackalamannil | |||
| Ho-Sam Ahn | |||
| P433 | issue | 28 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | thrombosis | Q261327 |
| pharmacology | Q128406 | ||
| P304 | page(s) | 2349-2365 | |
| P577 | publication date | 2003-01-01 | |
| P1433 | published in | Current Pharmaceutical Design | Q5195068 |
| P1476 | title | Development of proteinase-activated receptor 1 antagonists as therapeutic agents for thrombosis, restenosis and inflammatory diseases | |
| Development of Proteinase-Activated Receptor 1 Antagonists as Therapeutic Agents for Thrombosis, Restenosis and Inflammatory Diseases | |||
| P478 | volume | 9 |
| Q21245222 | Analysis of arterial intimal hyperplasia: review and hypothesis |
| Q33520217 | Enhancement of pig embryonic implants in factor VIII KO mice: a novel role for the coagulation cascade in organ size control |
| Q42439415 | Interleukin 8 is differently expressed and modulated by PAR-1 activation in early and late endothelial progenitor cells. |
| Q45068573 | Matrix Metalloprotease-1 and Elastase Are Novel Uterotonic Agents Acting Through Protease-Activated Receptor 1. |
| Q40464605 | Matrix Metalloproteinase 1 Causes Vasoconstriction and Enhances Vessel Reactivity to Angiotensin II via Protease-Activated Receptor 1. |
| Q47223491 | Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease |
| Q37312105 | Novel role for p21-activated kinase 2 in thrombin-induced monocyte migration |
| Q89660231 | Protease Amplification of the Inflammatory Response Induced by Commensal Bacteria: Implications for Racial Disparity in Term and Preterm Birth |
| Q40118103 | Protease-activated receptor 1-selective antagonist SCH79797 inhibits cell proliferation and induces apoptosis by a protease-activated receptor 1-independent mechanism |
| Q40010554 | Selecting optimal antiplatelet therapy based on platelet function monitoring in patients with coronary artery disease |
| Q28246124 | Thrombin and vascular inflammation |
| Q38087217 | Treating seizures and epilepsy with anticoagulants? |
Search more.